经尿道等离子双极电切术治疗前列腺增生的临床分析

Clinical analysis of transurethral plasmakinetic resection in the treatment of benign prostatic hyperplasia

目的评价等离子双极电切治疗前列腺增生的疗效、安全性及短期结果。方法将99例前列腺增生患者随机分成两组,49例归纳入等离子双极电切组,50例归纳入气化电切组,所有患者术前给予相关指标及术后半年随访结果评估。结果两组患者术前情况相似,所有患者均手术成功。术后尿管留置时间、术后住院时间等离子双极电切组均明显少于气化电切组,且两组患者术后1、3及6个月在IPSS、Qmax指标方面,等离子双极电切组均明显优于气化电切组(P<0.05)。结论等离子双极电切术在效率、安全性及短期结果方面明显优于气化电切组,是前列腺增生患者的另一种更好的治疗方案。

Objective To evaluate the efficiency, safety and short term outcome of transurethral resection in saline plasma vaporization of the prostate（TUPKP）. Methods 99 BPH patients were divided in to 2 groups, 49 patients underwent transurethral prostatectomy with TUPKP, and 50 patients underwent TURP＋TUVP. All patients were evaluated preoperatively and 6 months after surgery by related indicators. Results Patients from both series had similar preoperative characteristics. TUPKP and TURP＋TUVP ,sere successfully performed in all cases, the catheterization period and hospital stay were significantly shorter for TUPKP patients. At the 1, 3 and 6 months follow-ups,improvements in the variables measured were better in the TUPKP group： the IPSS and the Qmax（all P 〈 0.05）. Conclusion The efficiency, safety and short term results of TUPKP are significantly better than TURP＋TUVP.It is another better treatment for patients with BPH.